Why settle for average when you can shape the future of health in one of Europe’s top life sciences ecosystems? The 2025 Entrepreneurial Ecosystem Index confirms it: the Agglomeration Leiden–Bollenstreek now ranks #3 in the Netherlands, surpassing Brainport and closing in on Amsterdam. That’s a sign of long-term momentum for our region.
Because of consistent investment in what matters:
It isn’t a one-year spike either, but a structural improvement that reflects how public institutions and private companies have collaborated to create an environment where life sciences can thrive.
If you’re growing a biotech, medtech, or pharmaceutical business in Europe, Leiden is one of the few places where research, business, and regulation are within walking distance. It’s where new ideas become therapies. Where regional collaboration is the norm. And where growth is matched with talent. The data backs it up. Now is the time to be part of it.
Credits to the authors Utrecht University (Erik Stam) and Birch Consultants’ authors (Tom Hendricksen, Jan Peter van den Toren, Bram Schoenmakers)
Here’s the full report and what’s your takeaway?
A month after being cleared to sell its animal-free meat fat in the US, Nourish Ingredients has set its sights on the global market with a new commercial hub in the Netherlands....
Dutch biotech Leyden Labs has raised a €30 million equity investment from the European Innovation Council (EIC) Fund and Invest-NL to accelerate the development of its PanFlu...
Leiden, 26 September 2025. For the first time, LUMC has used a surgical robot to remove a piece of liver from a living donor and successfully transplant it into a patient. A...